Related Experiment Videos

Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity

Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|January 1, 1984
PubMed

Insights

Erythromycin estolate causes significant liver cell death and impairs calcium transport in rats, unlike other forms. This hepatotoxicity is linked to its surfactant component, sodium lauryl sulfate, and disrupted calcium homeostasis.

Area of Science:

  • Pharmacology
  • Hepatology
  • Cell Biology

Background:

  • Erythromycin estolate is a macrolide antibiotic known for its hepatotoxic potential.
  • Understanding the mechanisms of drug-induced liver injury is crucial for patient safety.

Purpose of the Study:

  • To investigate the effects of erythromycin estolate on isolated rat hepatocyte viability.
  • To examine the impact of erythromycin estolate on subcellular calcium (Ca2+) transport.

Main Methods:

  • Isolated rat hepatocytes were incubated with erythromycin estolate, erythromycin base, and erythromycin ethylsuccinate.
  • Mitochondrial and microsomal Ca2+ sequestration activities were measured.
  • The effects of sodium lauryl sulfate were also assessed.

Main Results:

  • Erythromycin estolate (0.5 mM) induced 100% cell death within 60 minutes.
  • Maximal inhibition of mitochondrial and microsomal Ca2+ sequestration occurred at 0.1 mM erythromycin estolate.
  • Sodium lauryl sulfate mimicked the hepatotoxic effects of erythromycin estolate.

Conclusions:

  • Erythromycin estolate exhibits significant hepatotoxicity in isolated rat hepatocytes.
  • Disruption of intracellular calcium homeostasis appears to mediate the hepatotoxic effects of erythromycin estolate, particularly its surfactant component.

Related Concept Videos